Mercilon ® – oral contraceptive in adolescent fertility control 

Mercilon ® – oral contraceptive in adolescent fertility control 

M Pavlov-Mirkovic and M Bogavac 

Clinical Centre Novi Sad, Department of Obstetrics

and Gynecology, Novi Sad, Serbia & Montenegro 

Introduction Sexuality in young’s

become an important problem due to its social, health and demographic

implications. As we move into the new millennium, various techniques will become

available which will help in the management of adolescent girls with

gynaecological problems. The aim of this study was to investigate the use of low

dose oral contraception containing 0.02 mg ethinylestradiol and 0.15 desogestrel

(Mercilon Organon) and its influence on bleeding pattern. 

Study methods Totally

230 girls under 20 year. The mean age 18.4, used the low dose oral contraception

for 6 months. The pill was taken 21 days with free period of seven days.

Duration and frequency of bleeding were evaluated. 

Results The majority of

girls had regular bleeding, the withdrawal bleeding during free period missed in

0.8% cycles. Bleeding duration was 2-4 days, mostly without pain and not heavy.

Spotting occurred in 6.5% of cycles and breakthrough bleeding in 3.1% of cycles. 

Conclusion Mercilon Organon containing 0.02 mg

ethinylestradiol and 0.15

dezogestrel besides high contraceptive reliability, is very good in regulation

duration, intensity and frequency of withdrawal bleeding. These results show

excellent cycle control, efficacy and very low rate of side effects.

Scroll to Top